Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

International Journal of Oncology

Volumn 30, Issue 6, 2007, Pages 1325-1332

  Negoro, Kenji ^a   Yamano, Yukio ^b   Fushimi, Kazuaki ^b   Saito, Kengo ^b   Nakatani, Ken ^a   Shiiba, Masashi ^b   Yokoe, Hidetaka ^d   Bukawa, Hiroki ^d   Uzawa, Katsuhiro ^b   Wada, Takeshi ^a   Tanzawa, Hideki ^b,c,d   Fujita, Shigeyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Department of Clinical Molecular Biology ^*  (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cisplatin; Drug resistance; Microarray; MTT assay; Pathway analysis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; CELL STRAIN KB; DNA MICROARRAY; DRUG RESISTANCE; GENE; GENETICS; HUMAN; MOUTH TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENES, MDR; HUMANS; KB CELLS; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34447283068     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.6.1325     Document Type: Article

References (26)

1. Reed E, Ozols RF, Tarone R, Yuspa SH and Poirier MC: Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. Proc Natl Acad Sci USA 84: 5024-5028, 1987. (Pubitemid 17095857)
2. Rosenberg B: Fundamental studies with cisplatin. Cancer 55: 2303-2316, 1985.
3. Reed E, Ozols RF, Tarone R, Yuspa SH and Poirier MC: The measurement of cisplatin-DNA adduct levels in testicular cancer patients. Carcinogenesis 9: 1909-1911, 1988.
4. Cognetti F, Pinnaro P, Carlini P, Ruggeri EM, Ambesi Impiombato F, Del Vecchio MR, Giannarelli D and Perrino A: Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer 62: 251-261, 1988.
5. Decker DA, Drelichman A, Jacobs J, Hoschner J, Kinzie J, Loh JJ, Weaver A and Al-Sarraf M: Adjuvant chemotherapy with cis-diamminodichloroplatinum and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51: 1353-1355, 1983.
6. Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, Posner MR, Norris CM Jr, Tuttle SA and Schoenfeld DA: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of the head and neck. J Clin Oncol 5: 10-20, 1987. (Pubitemid 17007851)
7. Makimoto T, Tsuchiya S, Nakano H, Watanabe S, Minato K, Takise A, Ezawa K, Fueki N, Naruse I, Nomoto T, Takei Y, Ishihara S, Mori M and Saitoh R: A phase II study of carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer. Am J Clin Oncol 20: 51-54, 1997. (Pubitemid 27066478)
8. Higuchi E, Oridate N, Furuta Y, Suzuki S, Hatakeyama H, Sawa H, Sunayashiki-Kusuzaki K, Yamazaki K, Inuyama Y and Fukuda S: Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and cDNA microarray. Head Neck 25: 187-193, 2003.
9. Scotto KW and Bertino JR: Natural and acquired resistance to chemotherapeutic agents. The molecular basis of cancer. 2nd edition. W.B. Sanders Co, pp407-422, 2001.
10. Jin S and Scotto KW: Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol 18: 4377-4384, 1998.
11. Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, Sugimachi K and Kuwano M: Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 6: 2401-2407, 2000.
12. Perez RP: Cellular and molecular determinants of cisplatin resistance. Eur J Cancer 34: 1535-1542, 1998. (Pubitemid 28446333)
13. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD: Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res 54: 5036-5040, 1994.
14. Futscher BW, Abbaszadegan MR, Domann F and Dalton WS: Analysis of MRP mRNA in mitoxantrone-selected, multidrug-resistant human tumor cells. Biochem Pharmacol 47: 1601-1606, 1994.
15. Kamazawa S, Kigawa J, Kanamori Y, Itamochi H, Sato S, Iba T and Terakawa N: Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer. Gynecol Oncol 86: 171-176, 2002. (Pubitemid 34953500)
16. Ishikawa T and Ali-Osman F: Glutathione-associated cis- diamminedichloroplatinum (II) metabolism and ATP-dependent efflux from leukemia cells: molecular characterization of glutathione-platinum complex and its biological siginificance. J Biol Chem 268: 20116-20125, 1993. (Pubitemid 23278910)
17. Kartalou M and Essigmann JM: Mechanism of resistance to cisplatin. Mutat Res 478: 23-43, 2001.
18. Zhang P, Zhang Z, Zhou X, Qiu W, Chen F and Chen W: Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer 6: 224, 2006.
19. Hong WS, Saijo N, Sasaki Y, Minato K, Nakano H, Nakagawa K, Fujuwara Y and Nomura K: Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines. Int J Cancer 41: 462-467, 1988.
20. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated calorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987. (Pubitemid 17027905)
21. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Immunol Methods 65: 55-63, 1983.
22. Ariyoshi Y, Shimahara M and Tanigawa N: Study on chemosensitivity of oral squamous cell carcinomas by histoculture drug response assay. Oral Oncol 39: 701-707, 2003. (Pubitemid 36930118)
23. Sawada S, Mese H, Sasaki A, Yoshioka N and Matsumura T: Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line. Cancer Chemother Pharmacol 51: 505-511, 2003.
24. Hong WS, Saijo N, Sasaki Y, Minato K, Nakano H, Nakagawa K, Fujiwara Y, Nomura K and Twentyman PR: Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines. Int J Cancer 41: 462-467, 1988.
25. Nakatani K, Nakamura M, Uzawa K, Wada T, Seki N, Tanzawa H and Fujita S: Establishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma. Oncol Rep 13: 709-714, 2005.
26. Nakamura M, Nakatani K, Uzawa K, Ono K, Uesugi H, Ogawara K, Shiiba M, Bukawa H, Yokoe H, Wada T, Fujita S and Tanzawa H: Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R. Oncol Rep 14: 1281-1286, 2005. (Pubitemid 40966254)